{
    "code": "02022116",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02022116",
    "time": "2015-08-23 11:12:52",
    "許可證字號": "衛署藥輸字第022116號",
    "註銷狀態": "已註銷",
    "註銷日期": "99\/08\/16",
    "註銷理由": "屆期未申請展延",
    "有效日期": "92\/04\/08",
    "發證日期": "87\/04\/08",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202211608",
    "中文品名": "愛德生凍晶注射劑",
    "英文品名": "ELDISINE LYOPHILIZED INJECTION",
    "適應症": "兒童急性淋巴胚芽細胞白血病變、慢性骨髓白血病的胚芽細胞危變、惡性黑色素瘤。",
    "劑型": "243凍晶注射劑",
    "包裝": "瓶裝 小瓶",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "主成分略述": "VINDESINE SULFATE",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "1411301100  臺灣禮來股份有限公司",
    "申請商地址": "台北巿復興北路３６５號１１樓",
    "主製造廠": {
        "製造廠名稱": "F150118000  LILLY FRANCE S.A.",
        "製造廠廠址": "RUE DU COLONEL LILLY 67640 FEGERSHEIM, FRANCE.203, BUREAUX DE LA COLLINE, 92213 SAINT CLOUD, FRANCE",
        "製造廠公司地址": "203, BUREAUX DE LA COLLINE, 92213 SAINT CLOUD, FRANCE",
        "製造廠國別": "FRANCE",
        "製程": ""
    },
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1002000410",
            "成分名稱": "VINDESINE SULFATE",
            "含量描述": "1",
            "含量": "1.0000000000",
            "單位": "MG"
        }
    ]
}